Charles River Laboratories | CRL - Operating Profit

Stock Price
168.49
Daily Change
2.43 1.46%
Monthly
-24.22%
Yearly
0.32%
Q1 Forecast
163.68

Charles River Laboratories reported $75.82M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Agilent USD 443M 66M Sep/2025
Align Technology USD 224.71M 40.06M Dec/2025
Bio-Rad Laboratories USD 63.9M 13.2M Sep/2025
Bruker USD 76.3M 7.6M Dec/2025
Cardinal Health USD 763M 9M Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Cigna USD 2.75B 240M Sep/2025
Concord Medical Services Hldg CNY -214.02M 126.95M Jun/2023
CVS Health USD 2.11B 836M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Dentsply International USD 512M 401M Sep/2025
Elevance Health USD 581M 1.18B Dec/2025
Galapagos EUR -41.67M 15.36M Sep/2025
Hologic USD 237M 16M Dec/2025
Humana USD -808M 1.21B Dec/2025
Illumina USD 256M 6M Dec/2025
Incyte USD 383.88M 47.43M Dec/2025
Intrexon USD -60.84M 26.62M Jun/2024
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Laboratory Of America USD 382M 15.3M Dec/2025
Lonza CHF 430M 104M Dec/2024
McKesson USD 1.66B 159M Dec/2025
Merck EUR 1.21B 180M Sep/2025
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Novartis USD 4.5B 363M Sep/2025
Pfizer USD 4.65B 3.99B Dec/2025
Quest Diagnostics USD 386M 0 Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
UnitedHealth USD 3.26B 1.06B Dec/2025
Veradigm USD 25M 30.36M Sep/2022
Waters USD 270.52M 78.4M Dec/2025
West Pharmaceutical Services USD 162.5M 5.1M Dec/2025